Heart rate as a therapeutic target in heart failure

被引:0
|
作者
Kjekshus, J [1 ]
Gullestad, L [1 ]
机构
[1] Univ Oslo, Cardiol Sect, Dept Med, Rikshosp, N-0027 Oslo, Norway
关键词
sympathetic activity; congestive heart failure; beta-receptor blockade; beta-blocker; myocardial infarction;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Resting heart rate has prognostic importance regarding late cardiovascular mortality and morbidity. Hypertension and heart failure are often associated with increased resting heart rate. The resting heart rate is an index of dominant sympathetic nervous activity which may increase coronary vasoconstriction, enhance myocardial oxygen consumption, reduce diastolic perfusion time, increase endothelial shear stress and platelet aggregation, release growth factors and increase plaque instability. Reduction of heart rate by beta-receptor blockade has been shown to delay and limit enzyme release during acute myocardial infarction. Reduction in heart rate by at least 15 beats. min(-1) during. infarct evolution has been associated with a reduction in infarct size of between 25 and 30%. However. it is suggested that a reduction in heart rate of less than 8 beats.min(-1) has no effect. In large controlled clinical trials beta-blockade has reduced mortality by 15% during acute myocardial infarction. The benefit is larger among patients with left ventricular dysfunction, enlarged hearts, symptomatic heart failure and elevated heart rates. The effect is improved if treatment is started early during infarct evolution, (less than 4 h after onset of symptoms): however, none of the trials have specifically tested early intervention during infarct evolution. Comparison between placebo and drug intervention in patients with signs of heart failure suggests a relationship between the reduction of resting heart rate and the percentage reduction of mortality obtained in each trial. beta-blocker treatment has the largest potential to reduce heart rate. Confounding properties of a beta-blocker, such as intrinsic sympatomimetic activity or prolongation of the QT interval, may reduce its overall efficacy. These results suggest that the beneficial effect of beta-blockers in heart failure is related to the blocking of the sympathetic activity, as reflected in a quantitative reduction in heart rate and increase in diastolic time.
引用
收藏
页码:H64 / H69
页数:6
相关论文
共 50 条
  • [1] Heart rate as a therapeutic target in heart failure?
    Tavazzi, L
    [J]. EUROPEAN HEART JOURNAL SUPPLEMENTS, 2003, 5 (0G) : G15 - G18
  • [2] Heart rate as a prognostic marker and therapeutic target in acute and chronic heart failure
    Oliva, Fabrizio
    Sormani, Paola
    Contri, Rachele
    Campana, Carlo
    Carubelli, Valentina
    Ciro, Antonio
    Morandi, Fabrizio
    Di Tano, Giuseppe
    Mortara, Andrea
    Senni, Michele
    Metra, Marco
    Ammirati, Enrico
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 253 : 97 - 104
  • [3] Heart rate as a therapeutic target in heart failure: analysis of 1000 consecutive outpatient appointments to a heart failure clinic
    Dierckx, R.
    Parsons, S.
    Putzu, P.
    Dicken, B.
    Pellicori, P.
    Zhang, J.
    Weston, J.
    Davis, J.
    Clark, A.
    Cleland, J.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 : 267 - 267
  • [4] HEART RATE AS A THERAPEUTIC TARGET IN HEART FAILURE: ANALYSIS OF 1000 CONSECUTIVE OUTPATIENT APPOINTMENTS TO A HEART FAILURE CLINIC
    Dierckx, Riet
    Parsons, Sunaina
    Putzu, Paola
    Dicken, Benjamin
    Pellicori, Pierpaolo
    Zhang, Jufen
    Clark, Andrew
    Cleland, John
    [J]. HEART, 2014, 100 : A30 - A31
  • [5] Is Heart Rate a Treatment Target in Heart Failure?
    Reil, Jan-Christian
    Boehm, Michael
    [J]. CURRENT CARDIOLOGY REPORTS, 2012, 14 (03) : 308 - 313
  • [6] Is Heart Rate a Treatment Target in Heart Failure?
    Jan-Christian Reil
    Michael Böhm
    [J]. Current Cardiology Reports, 2012, 14 : 308 - 313
  • [7] β-blocker therapy for heart failure:: Should the therapeutic target be dose or heart rate reduction?
    Butler, J
    Khadim, G
    Simbaqueba, C
    Goring, J
    Giesberg, C
    Khalid, A
    Anwar, F
    Fee, M
    Champney, K
    Chomsky, O
    [J]. CIRCULATION, 2004, 110 (17) : 431 - 431
  • [8] Heart rate as a therapeutic target in ischaemic heart disease
    Purcell, H
    [J]. EUROPEAN HEART JOURNAL SUPPLEMENTS, 1999, 1 (0H) : H58 - H63
  • [9] Heart rate as a target of treatment of chronic heart failure
    Hori, Masatsugu
    Okamoto, Hiroshi
    [J]. JOURNAL OF CARDIOLOGY, 2012, 60 (1-2) : 86 - 90
  • [10] The vasculature: a therapeutic target in heart failure?
    Luxan, Guillermo
    Dimmeler, Stefanie
    [J]. CARDIOVASCULAR RESEARCH, 2022, 118 (01) : 53 - 64